Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Feasibility Study of Intraperitoneal Bevacizumab for Palliation of Intractable Malignant Ascites

NCT02496286 is registered in ClinicalTrials.gov with Eastern Regional Medical Center as lead sponsor.

NCT NCT02496286
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02496286 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Feasibility Study of Intraperitoneal Bevacizumab for Palliation of Intractable Malignant Ascites
Lead sponsor
Eastern Regional Medical Center
Phase
Phase 1
Overall status
Terminated
Start date
June 30, 2015
Completion date
August 31, 2015
Enrollment
10 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

malignant ascites